LOINC Code 12084-0: Fetal Tricuspid valve Study observation US
12084-0 is a LOINC code used to identify Fetal Tricuspid valve Study observation US in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Study observation. It is commonly used with the system or sample type Tricuspid valve^Fetus.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Study observation. It is commonly used with the system or sample type Tricuspid valve^Fetus.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Observation
- Method: US
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Fetal Tricuspid valve Study observation US
- Study observation
- Cardio; Cardiology; Echography; Fetal; Finding; Findings; Gyn; Gynecology; Heart Disease; Nominal; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Point in time; Random; Sonogram; Sonograph; Sonography; Study report; TV; ULS; Ultrasound
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.